The Zacks Analyst Blog Highlights: Clorox, Unilever, Church & Dwight and Reckitt Benckiser Group

Stock prices increasing and decreasing in value
Credit: Shutterstock photo

For Immediate Release

Chicago, IL - June 27, 2017 - announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Clorox Inc. (NYSE: CLX- Free Report ), Unilever Plc (NYSE: UL- Free Report ), Church & Dwight Company Inc. (NYSE: CHD- Free Report ) and Reckitt Benckiser Group PLC (OTCMKTS: RBGLY- Free Report ).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free .

Here are highlights from Tuesday's Analyst Blog:

4 Reasons to Retain Clorox (CLX) Stock in Your Portfolio

Holding on to stocks with solid growth potential is prudent for investors looking for solid returns. One such stock is the consumer products seller, Clorox Inc. (NYSE: CLX- Free Report ), which is doing well on the back of its solid surprise trend, robust outlook, impressive stock performance, progress on 2020 Strategy, diversified brand portfolio and disciplined capital strategy. The stock also has a long-term earnings growth rate of 6.8%. So, let's get a better understanding of how these traits are working for the company.

Robust Earnings History & Outlook

Clorox earnings history reveals that the company has delivered positive earnings surprise in six of the last eight quarters, with third-quarter fiscal 2017 marking its second consecutive beat. While top-line results for the last reported quarter were marginally short of estimates, it marked the company's first miss following four consecutive beats. The recent quarter results gained from strong sales, lower tax rate and gain from sale of an international facility that forms part of its Go Lean strategy. Further, sales were aided by improved volumes, contributions from RenewLife and better International pricing.

While Clorox expects the macroeconomic headwinds to persist going forward, it is all set to counter the hurdles with prudent strategies. The company plans to offset stiff competition with increased brand investments. Further, it is on track with the Go Lean strategy to fight slowing global economies. Moreover, the company aims to keep cost-savings and pricing in place, to battle the expected inflation and increasing commodity pricing.

Further, the company anticipates boosting sales and volumes in fourth-quarter fiscal 2017 driven by the intense advertising and promotion investments to enhance brand value that were incurred in the fiscal third quarter. It also envisions EBIT margin to improve in the fourth quarter backed by lower selling and administrative costs. That said, management remains confident of delivering another year of top and bottom-line growth.

Stock Movement

This Oakland, CA-based retailer has outperformed both the broader industry and sector in the past one month. Evidently, shares of Clorox advanced 5.9% in the past one month, compared with the Zacks categorized Soap and Cleaning Materials industry's growth of 2.9% and the Zacks categorized Consumer Staples sector's 0.5% upside. This is mainly attributable to its robust show even amid a tough retail landscape. This, in itself, speaks volumes about the company's ongoing prospects.

2020 Strategy

Clorox remains on track with the smooth execution of 2020 Strategy, which is aimed at augmenting growth for the improvement of categories and overall market share. The whole strategy is aimed at achieving certain long-term aspirations, including growing net sales by 3−5%, increasing EBIT margin by 25−50 basis points (bps) and generating free cash flow of 10−12% of sales, all on a yearly basis. Clorox anticipates achieving these targets through key accelerators like investment in brands, development of eCommerce, technological advancements; enhancement of growth culture and focus on the 3Ds - desire, decision and delight.

Diversified Brand Portfolio & Capital Strategy

Clorox's diversified brand portfolio positions the company well above peers to generate above-average industry growth and sustain itself in the currently challenging environment. The company's focus on boosting sales through brands is well-evident from constant innovations and marketing strategies to drive top-line growth. Incidentally, in the first quarter, the company raised trade promotion spending at a double-digit rate, to sponsor innovations and counter competition in some core categories. These resulted in sales and volume growth of 3.6% and 7%, respectively, in the fiscal third quarter, amid a challenging consumer environment.

The company has always maintained a disciplined capital allocation strategy, focused on making investments to develop business while using the excess cash to lower debts and enhance shareholder returns through dividend payouts and share buybacks. Moreover, its cash generation ability is also reflected in its tradition of returning excess cash to shareholders in the form of share buybacks and dividend payouts.

Bottom Line

While all is well with this mega consumer products company, its margins are likely to remain a concern due to the increased trade promotional investments which are aimed at supporting product innovation. However, we believe that Clorox's growth drivers far outweigh the obstacles and will help the company sustain its impressive momentum.

However, investors interested in the space can count on Unilever Plc (NYSE: UL- Free Report ), Church & Dwight Company Inc. (NYSE: CHD- Free Report ) and Reckitt Benckiser Group PLC (OTCMKTS: RBGLY- Free Report ).

Unilever, with long-term EPS growth rate of 12%, has increased 9.4% in the last three months.

Church & Dwight has to its credit a spectacular earnings history as the company delivered an average positive earnings surprise of 6.3% in the past four quarters. Moreover, it has a long-term EPS growth rate of 9.2%.

Reckitt Benckiser, with long-term EPS growth rate of 15.5%, has grown 9.7% in the last three months.

The Best & Worst of Zacks

Today you are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 ""Strong Buys"" free of charge. From 1988 through 2015 this list has averaged a stellar gain of +25% per year. Plus, you may download 220 Zacks Rank #5 ""Strong Sells."" Even though this list holds many stocks that seem to be solid, it has historically performed 6X worse than the market. See these critical buys and sells free >>

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Get the full Report on CLX - FREE

Get the full Report on UL - FREE

Get the full Report on CHD - FREE

Get the full Report on RBGLY - FREE

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Clorox Company (The) (CLX): Free Stock Analysis Report

Unilever PLC (UL): Free Stock Analysis Report

Church & Dwight Company, Inc. (CHD): Free Stock Analysis Report

Reckitt Benckiser Group PLC (RBGLY): Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

    Learn More